An analysis of US fertility centre educational materials suggests that informed consent for preimplantation genetic diagnosis may be inadequate

Journal of Medical Ethics

Volumn 38, Issue 8, 2012, Pages 479-484

  LaBonte, Michelle Lynne ^a  

^a WELLESLEY COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ETHICS; FEMALE; FERTILITY; HUMAN; INFORMED CONSENT; METHODOLOGY; OUTPATIENT DEPARTMENT; PATIENT EDUCATION; PREGNANCY; PRENATAL DIAGNOSIS; STANDARD; TEACHING; UNITED STATES;

AMBULATORY CARE FACILITIES; FEMALE; FERTILITY; HUMANS; INFORMED CONSENT; PATIENT EDUCATION AS TOPIC; PREGNANCY; PREIMPLANTATION DIAGNOSIS; TEACHING MATERIALS; UNITED STATES;

EID: 84866316331     PISSN: 03066800     EISSN: 14734257     Source Type: Journal    
DOI: 10.1136/medethics-2011-100154     Document Type: Article

References (32)

1. CDC. 2008 Assisted Reproductive Technology Success Rates: National Summary and Fertility Clinic Reports. 2010. http://www.cdc.gov/art/ART2008/index.htm (accessed 11 Apr 2011).
2. Baruch S, Kaufman D, Hudson K. Genetic testing of embryos: practices and perspectives of US in vitro fertilization clinics. Fertil Steril 2008;89:1053-8.
3. Ginsburg ES, Baker VL, Racowsky C, et al. Use of preimplantation genetic diagnosis and preimplantation genetic screening in the United States: a Society for Assisted Reproductive Technology Writing Group paper. Fertil Steril 2011;96:865-8.
4. Liebaers I, Desmyttere S, Verpoest W, et al. Report on a consecutive series of 581 children born after blastomere biopsy for preimplantation genetic diagnosis. Hum Reprod 2010;25:275e82.
5. Banerjee I, Shevlin M, Taranissi M, et al. Health of children conceived after preimplantation genetic diagnosis: a preliminary outcome study. Reprod BioMed Online 2008;16:376-81.
6. Desmyttere S, Bonduelle M, Nekkebroeck J, et al. Growth and health outcome of 102 2-year-old children conceived after preimplantation genetic diagnosis or screening. Early Hum Dev 2009;85:755-9.
7. Nekkebroeck J, Bonduelle M, Desmyttere S, et al. Mental and psychomotor development of 2-year-old children born after preimplantation genetic diagnosis/screening. Hum Reprod 2008;23:1560-6.
8. Nekkebroeck J, Bonduelle M, Desmyttere S, et al. Socio-emotional and language development of 2-year-old children born after PGD/PGS, and parental well-being. Hum Reprod 2008;23:1849-57.
9. Middelburg KJ, Heineman MJ, Haadsma ML, et al. Neurological condition of infants born after in vitro fertilization with preimplantation genetic screening. Pediatr Res 2010;67:430e4.
10. Middelburg KJ, van der Heide M, Houtzager B, et al. Mental, psychomotor, neurologic, and behavioral outcomes of 2-year-old children born after preimplantation genetic screening: follow-up of a randomized controlled trial. Fertil Steril 2011;96:165-9.
11. Yu Y, Wu J, Fan Y, et al. Evaluation of blastomere biopsy using a mouse model indicates the potential high risk of neurodegenerative disorders in the offspring. Mol Cell Proteomics 2009;8:1490-500.
12. Kalfoglou A, Scott J, Hudson K. PGD patients' and providers' attitudes to the use and regulation of preimplantation genetic diagnosis. Reprod Biomed Online 2005;11:486-96.
13. McGowan ML, Burant CJ, Moran R, et al. Patient education and informed consent for preimplantation genetic diagnosis: health literacy for genetics and assisted reproductive technology. Genet Med 2009;11:640-645.
14. Cowan RS. Heredity and Hope: The Case for Genetic Screening. Cambridge, MA: Harvard University Press, 2008.
15. Franklin S, Roberts C. Born and Made: An Ethnography of Preimplantation Genetic Diagnosis. Princeton, NJ: Princeton University Press, 2010.
16. Patel R. Waiting for Harrison. Good Housekeeping 2005;240:102-6.
17. Springen K, Cowley G. Risk-free babies. Newsweek 11 March 2002. http://www.newsweek.com/2002/03/10/risk-free-babies.html (accessed 26 May 2011).
18. Genetics and Public Policy Centre. Reproductive Genetic Testing: What America Thinks. 2004. http://www.DNApolicy.org (accessed 1 May 2011).
19. Brandt A. The Cigarette Century: The Rise, Fall, and Deadly Persistence of the Product that Defined America. New York, NY: Basic Books, 2007.
20. Lambrozo J, Lynch CG. Managing scientific uncertainty in environmental health: the example of electric and magnetic fields. J Contingencies Crisis Manag 2000;8:229-33.
21. Gross SE, Shuval JT. On knowing and believing: prenatal screening and resistance to 'risk-medicine'. Heath Risk Soc 2008;10:549-64.
22. Dennis C. Deaf by design. Nature 2004;431:894-6.
23. Naik G. A baby, please. blond, frecklesdhold the colic. Wall St J 12 February 2009. http://online.wsj.com/article/SB123439771603075099.html (accessed 28 Jul 2011).
24. Hudson K. Preimplantation genetic diagnosis: public policy and public attitudes. Fertil Steril 2006;85:1638-45.
25. Beck U. Risk society revisited: theory, politics, critiques, and research programmes. World Risk Society. Cambridge, MA: Polity Press, 1999:133-52.
26. Kimmelman J. The ethics of human gene transfer. Nat Rev Genet 2008;9:239-44.
27. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003;302:415-19.
28. Kohn DB, Sadelain M, Glorioso JC. Occurrence of leukaemia following gene therapy of X-linked SCID. Nat Rev Cancer 2003;3:477-88.
29. Wilson JM. Lessons learned from the gene therapy trial for ornithine transcarbamylase deficiency. Mol Genet Metab 2009;96:151-7.
30. Spar DL. The Baby Business. Cambridge, MA: Harvard Business School Press, 2006.
31. Baruch S. Preimplantation genetic diagnosis and parental preferences: beyond deadly disease. Houst J Health Law Policy 2008;8:245-70.
32. Beck U. World at Risk. Cambridge, UK: Polity Press, 2007.